Published August 31, 2016 | Version v1
Journal article

Aryl hydrocarbon receptor–ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism

  • 1. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 2. Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Taiwan (China)
  • 3. Center for Research Resources and Development, Kaohsiung Medical University, Taiwan (China)
  • 4. Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 5. Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 6. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (China)
  • 7. Department of Molecular Prevention Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo (Japan)
  • 8. Faculty of Science and Engineering, Department of Pharmacological Science, Tokushima Bunri University, Sanuki (Japan)
  • 9. Center for Infectious Diseases and Cancer, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 10. Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  • 11. National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County, Taiwan (China)

Description

Pulmonary fibroblast migration and differentiation are critical events in fibrogenesis; meanwhile, fibrosis characterizes the pathology of many respiratory diseases. The role of aryl hydrocarbon receptor (AhR), a unique cellular chemical sensor, has been suggested in tissue fibrosis, but the mechanisms through which the AhR-ligand axis influences the fibrotic process remain undefined. In this study, the potential impact of the AhR-ligand axis on pulmonary fibroblast migration and differentiation was analyzed using human primary lung fibroblasts HFL-1 and CCL-202 cells. Boyden chamber-based cell migration assay showed that activated AhR in HFL-1cells significantly enhanced cell migration in response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD), and a known AhR antagonist, CH223191, inhibited its migratory activity. Furthermore, the calcium mobilization and subsequent upregulated expression of arachidonic acid metabolizing enzymes, including cyclooxygenase2 (COX-2) and 5-lipoxygenase (5-LOX), were observed in TCDD-treated HFL-1 cells, concomitant with elevated levels of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) secretion. Also, significantly increased expression of α-smooth muscle actin α-SMA), a fibroblast differentiation marker, was also noted in TCDD-treated HFL-1 cells (p < 0.05), resulting in a dynamic change in cytoskeleton protein levels and an increase in the nuclear translocation of the myocardin-related transcription factor. Moreover, the enhanced levels of α-SMA expression and fibroblast migration induced by TCDD, PGE2 and LTB4 were abrogated by selective inhibitors for COX-2 and 5-LOX. Knockdown of AhR by siRNA Completely diminished intracellular calcium uptake and reduced α-SMA protein verified by promoter-reporter assays and chromatin immunoprecipitation. Taken together, our results suggested the importance of the AhR-ligand axis in fibroblast migration and differentiation through its capacity in enhancing arachidonic acid metabolism.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.tox.2016.09.019

Additional details

Identifiers

DOI
10.1016/j.tox.2016.09.019;
PII
S0300-483X(16)30234-7;

Publishing Information

Journal Title
Toxicology
Journal Volume
370
Journal Page Range
p. 116-126
ISSN
0300-483X
CODEN
TXCYAC

Optional Information

Copyright
Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.